A Study with ABBV-155 Alone and in Combination with Taxane Therapy in Adults with Relapsed and/or Refractory Solid Tumors

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-513625-23-00

Acronym

M16-573

Enrollment

Registered

2024-07-18

Start date

2021-03-15

Completion date

2025-09-12

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

including: Small cell lung cancer (SCLC); Non-small cell cancer (NSCLC); Breast cancer, Patients with relapsed or refractory solid tumors

None listed

Sex/Gender

All

Age

18 Years to No maximum

Netherlands

None listed

Source: EU CTIS · Data processed: Feb 4, 2026